U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 050684

Expand all

ZOSYN (PIPERACILLIN SODIUM; TAZOBACTAM SODIUM)
EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
Proprietary Name: ZOSYN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N050684
Product Number: 001
Approval Date: Oct 22, 1993
Applicant Holder Full Name: WYETH PHARMACEUTICALS LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information
ZOSYN (PIPERACILLIN SODIUM; TAZOBACTAM SODIUM)
EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
Proprietary Name: ZOSYN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N050684
Product Number: 002
Approval Date: Oct 22, 1993
Applicant Holder Full Name: WYETH PHARMACEUTICALS LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information
ZOSYN (PIPERACILLIN SODIUM; TAZOBACTAM SODIUM)
EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
Proprietary Name: ZOSYN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N050684
Product Number: 003
Approval Date: Oct 22, 1993
Applicant Holder Full Name: WYETH PHARMACEUTICALS LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information
ZOSYN (PIPERACILLIN SODIUM; TAZOBACTAM SODIUM)
EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
Proprietary Name: ZOSYN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N050684
Product Number: 004
Approval Date: Oct 22, 1993
Applicant Holder Full Name: WYETH PHARMACEUTICALS LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information
Back to Top